Advertisement

Current Emergency and Hospital Medicine Reports

, Volume 4, Issue 3, pp 141–152 | Cite as

Importance of a Travel History in Evaluation of Respiratory Infections

  • Theresa N. Duong
  • Sarah E. WaldmanEmail author
Infectious Disease (H. Nguyen, Section Editor)
  • 88 Downloads
Part of the following topical collections:
  1. Infectious Disease

Abstract

Purpose of Review

International travel has increased at a fast pace and will continue to rapidly rise. Concomitantly, with this increase in travel is the increase in post travel-related diseases, such as respiratory illnesses. Identifying the cause of the posttravel respiratory illness is a complex challenge for many healthcare professionals because similar presentations occur for both infectious and noninfectious causes. Not only is diagnosis important but also transmission prevention. In the last two decades, there have been several severe infectious respiratory syndromes that have spread through international travel causing epidemics in many countries.

Recent Findings

A detailed travel history with the chronology of symptoms paired with the patient's medical risk factors and exposures along with some basic knowledge of infectious respiratory illnesses will help facilitate clinical decision making. This framework will help create a broad, but appropriate differential diagnosis to guide clinical workup, prevent delays in diagnosis, and implement the appropriate precautions to prevent transmission if appropriate.

Summary

The foundation to diagnosing a travel-related respiratory illness lies within integrating the patient's travel history, comorbid conditions, clinical presentation, exposures, and mode of transmission. A timely and accurate diagnosis benefits not only the patient but also the surrounding community to prevent further individual transmission, epidemics, and pandemics.

Keywords

Travel history Respiratory infections Travel-related illness 

Notes

Compliance with Ethical Guidelines

Conflict of Interests

Drs May & Okamoto declare no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain studies with human or animal subjects performed by the author.

References

Papers of particular interest, published recently, are highlighted as: •• Of major importance

  1. 1.
    UNWTO WTO. International tourist arrivals up 4% reach a record 1.2 billion in 2015. [Press Release]. 2016; http://media.unwto.org/press-release/2016-01-18/international-tourist-arrivals-4-reach-record-12-billion-2015. Accessed April 16, 2016.
  2. 2.
    Sanford CA, Fung C. Illness in the returned international traveler. Med Clin North Am. 2016;100(2):393–409.CrossRefPubMedGoogle Scholar
  3. 3.
    Bruni MSR. Impact of travel-related health impairments. J Travel Med. 1997;4:61–4.CrossRefPubMedGoogle Scholar
  4. 4.
    Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006;354(2):119–30.CrossRefPubMedGoogle Scholar
  5. 5.
    •• Leder K, Torresi J, Libman MD, et al. GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med. Mar 19 2013;158(6):456–68. This is a comprehensive study that analyzes four years of GeoSentinel data that identifies the significant predictors for developing specific categories of respiratory infections based on demographic features and travel-related factors. Google Scholar
  6. 6.
    CDC. Travelers’ Health. 2016; http://wwwnc.cdc.gov/travel.
  7. 7.
    George RB, Payne DK. The respiratory history and physical examination. In: George RB, Matthay MA, editors. Chest medicine essentials of pulmonary and critical care medicine. Philadelphia: Lipincott Williams and Wilkins; 2005.Google Scholar
  8. 8.
    Blair DC. A week in the life of a travel clinic. Clin Microbiol Rev. 1997;10(4):650–73.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Leder K, Sundararajan V, Weld L, et al. Respiratory tract infections in travelers: a review of the GeoSentinel surveillance network. Clin Infect Dis. 2003;36(4):399–406.CrossRefPubMedGoogle Scholar
  10. 10.
    Brownstein JS, Wolfe C, Mandl KD. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. 2006;3(10):e401.Google Scholar
  11. 11.
    Khan K, Arino J, Hu W, et al. Spread of a novel influenza A (H1N1) virus via global airline transportation. N Engl J Med. 2009;361(2):212–4.CrossRefPubMedGoogle Scholar
  12. 12.
    Mangili AGM. Transmission of infectious diseases during commercial air travel. Lancet. 2005;365(9463):989–96.CrossRefPubMedGoogle Scholar
  13. 13.
    Baker MG, Thornley CN, Mills C, et al. Transmission of pandemic A/H1N1 2009 influenza on passenger aircraft: retrospective cohort study. BMJ. 2010;340:c2424.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    •• Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160(21):3243–7. This is a pooled analysis of several studies that give supporting statistical evidence for specific clinical symptoms which can guide physicians in making a timely diagnosis of influenza when evaluating respiratory infections. Highlights the importance of knowing the prevalence of influenza in the community in one’s clinical decision making. Google Scholar
  15. 15.
    Boivin G, Hardy I, Tellier G, Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis. 2000;31(5):1166–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Zambon M, Hays J, Webster A, Newman R, Keene O. Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza. Arch Intern Med. 2001;161(17):2116–22.CrossRefPubMedGoogle Scholar
  17. 17.
    CDC. Influenza: Flu Activity and Surveillance. 2016; http://www.cdc.gov/flu/weekly/fluactivitysurv.htm. Accessed June 20, 2016.
  18. 18.
    Newton DW, Mellen CF, Baxter BD, Atmar RL, Menegus MA. Practical and sensitive screening strategy for detection of influenza virus. J Clin Microbiol. 2002;40(11):4353–6.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children–diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(8):1003–32.CrossRefPubMedGoogle Scholar
  20. 20.
    CDC. Influenza: Prevention Strategies for Seasonal Influenza in Healthcare Settings. 2016; http://www.cdc.gov/flu/professionals/infectioncontrol/healthcaresettings.htm. Accessed June 20, 2016.
  21. 21.
    Peiris JS, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med. 2004;10(12 Suppl):S88–97.CrossRefPubMedGoogle Scholar
  22. 22.
    WHO. Cumulative Number of Reported Probable Cases of SARS. http://www.who.int/csr/sars/country/2003_07_04/en/. Accessed May 15, 2016.
  23. 23.
    Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348(20):1986–94.CrossRefPubMedGoogle Scholar
  24. 24.
    Desenclos JC, van der Werf S, Bonmarin I, et al. Introduction of SARS in France, March-April, 2003. Emerg Infect Dis. 2004;10(2):195–200.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Olsen SJ, Chang HL, Cheung TY, et al. Transmission of the severe acute respiratory syndrome on aircraft. N Engl J Med. 2003;349(25):2416–22.CrossRefPubMedGoogle Scholar
  26. 26.
    Wilder-Smith A, Leong HN, Villacian JS. In-flight transmission of Severe Acute Respiratory Syndrome (SARS): a case report. J Travel Med. 2003;10(5):299–300.CrossRefPubMedGoogle Scholar
  27. 27.
    CDC. Cluster of Severe Acute Respiratory Syndrome Cases Among Protected Health-Care Workers—Toronto, Canada, April 2003. MObidity and Motality Weekly Report 2016; http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5219a1.htm. Accessed June 20, 2016.
  28. 28.
    Wilder-Smith A, Paton NI, Goh KT. Low risk of transmission of severe acute respiratory syndrome on airplanes: the Singapore experience. Trop Med Int Health. 2003;8(11):1035–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Vogt TM, Guerra MA, Flagg EW, Ksiazek TG, Lowther SA, Arguin PM. Risk of severe acute respiratory syndrome-associated coronavirus transmission aboard commercial aircraft. J Travel Med. 2006;13(5):268–72.CrossRefPubMedGoogle Scholar
  30. 30.
    WHO. Summary of SARS and air travel. http://www.who.int/csr/sars/travel/airtravel/en/. Accessed May 15, 2016.
  31. 31.
    Leung GM, Hedley AJ, Ho LM, et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med. 2004;141(9):662–73.CrossRefPubMedGoogle Scholar
  32. 32.
    Christian MD, Poutanen SM, Loutfy MR, Muller MP, Low DE. Severe acute respiratory syndrome. Clin Infect Dis. 2004;38(10):1420–7.CrossRefPubMedGoogle Scholar
  33. 33.
    CDC. Severe Acute Respiratory Syndrome (SARS). 2012; http://www.cdc.gov/sars/clinical/guidance.html. Accessed June 20, 2016.
  34. 34.
    Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289(21):2801–9.CrossRefPubMedGoogle Scholar
  35. 35.
    Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361(9371):1767–72.CrossRefPubMedGoogle Scholar
  36. 36.
    So LK, Lau AC, Yam LY, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet. 2003;361(9369):1615–7.CrossRefPubMedGoogle Scholar
  37. 37.
    Groneberg DA, Poutanen SM, Low DE, Lode H, Welte T, Zabel P. Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect Dis. 2005;5(3):147–55.CrossRefPubMedGoogle Scholar
  38. 38.
    Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3(9):e343.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Siegel JD, Rhinehart E, Jackson M, Chiarello L. Health Care Infection Control Practices Advisory C. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control. 2007;35(10 Suppl 2):S65–164.CrossRefPubMedGoogle Scholar
  40. 40.
    Seto WH, Tsang D, Yung RW, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet. 2003;361(9368):1519–20.CrossRefPubMedGoogle Scholar
  41. 41.
    Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–20.CrossRefPubMedGoogle Scholar
  42. 42.
    WHO. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - Saudia Arabia. Disease outbreak news 26 April 2016. http://www.who.int/csr/don/26-april-2016-mers-saudi-arabia/en/. Accessed May 15, 2016.
  43. 43.
    Assiri A, McGeer A, Perl TM, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013;369(5):407–16.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Oboho IK, Tomczyk SM, Al-Asmari AM, et al. 2014 MERS-CoV outbreak in Jeddah—a link to health care facilities. N Engl J Med. 2015;372(9):846–54.CrossRefPubMedGoogle Scholar
  45. 45.
    Memish ZA, Mishra N, Olival KJ, et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis. 2013;19(11):1819–23.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Azhar EI, El-Kafrawy SA, Farraj SA, et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med. 2014;370(26):2499–505.CrossRefPubMedGoogle Scholar
  47. 47.
    TWM-CR Group. State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans. PLoS Curr. 2013;5.Google Scholar
  48. 48.
    Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752–61.CrossRefPubMedGoogle Scholar
  49. 49.
    Hui DS, Memish ZA, Zumla A. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome. Curr Opin Pulm Med. 2014;20(3):233–41.CrossRefPubMedGoogle Scholar
  50. 50.
    Centers for Disease Control and Prevention (CDC). Pertussis in an infant adopted from Russia–May 2002. MMWR Morb Mortal Wkly Rep. 2002;51(18):394–5.Google Scholar
  51. 51.
    de Jong B, Payne Hallstrom L, Robesyn E, Ursut D, Zucs P. Travel-associated Legionnaires’ disease in Europe, 2010. Euro Surveill. 2013;18(23).Google Scholar
  52. 52.
    Dan M. Melioidosis in travelers: review of the literature. J Travel Med. 2015;22(6):410–4.CrossRefPubMedGoogle Scholar
  53. 53.
    Segel MJ, Rozenman J, Lindsley MD, et al. Histoplasmosis in Israeli travelers. Am J Trop Med Hyg. 2015;92(6):1168–72.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Xirotagaros G, Drogari-Apiranthitou M, Panayiotides IG, et al. Imported lymphocutaneous sporotrichosis in Greece. Br J Dermatol. 2015;173(1):291–3.CrossRefPubMedGoogle Scholar
  55. 55.
    Corpolongo A, Giancola ML, Ghirga P, et al. An imported case of acute pulmonary coccidioidomycosis in an Italian traveller. Infection. 2014;42(5):921–4.CrossRefPubMedGoogle Scholar
  56. 56.
    Buitrago MJ, Bernal-Martinez L, Castelli MV, Rodriguez-Tudela JL, Cuenca-Estrella M. Histoplasmosis and paracoccidioidomycosis in a non-endemic area: a review of cases and diagnosis. J Travel Med. 2011;18(1):26–33.CrossRefPubMedGoogle Scholar
  57. 57.
    Richaud C, Lebeaux D, Lortholary O. Fungal infections associated with travel. Curr Fungal Infect Rep. 2013;7(4):311–9.CrossRefGoogle Scholar
  58. 58.
    Lortholary O, Charlier C, Lebeaux D, Lecuit M, Consigny PH. Fungal infections in immunocompromised travelers. Clin Infect Dis. 2013;56(6):861–9.CrossRefPubMedGoogle Scholar
  59. 59.
    Wheat J. Endemic mycoses in AIDS: a clinical review. Clin Microbiol Rev. 1995;8(1):146–59.PubMedPubMedCentralGoogle Scholar
  60. 60.
    Emmons CW. Isolation of Histoplasma capsulatum from soil. Public Health Rep. 1949;64(28):892–6.CrossRefPubMedGoogle Scholar
  61. 61.
    Colombo AL, Tobon A, Restrepo A, Queiroz-Telles F, Nucci M. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol. 2011;49(8):785–98.PubMedGoogle Scholar
  62. 62.
    Bellissimo-Rodrigues F, Machado AA, Martinez R. Paracoccidioidomycosis epidemiological features of a 1,000-cases series from a hyperendemic area on the southeast of Brazil. Am J Trop Med Hyg. 2011;85(3):546–50.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Castillo CG, Kauffman CA, Miceli MH. Blastomycosis. Infect Dis Clin North Am. 2016;30(1):247–64.CrossRefPubMedGoogle Scholar
  64. 64.
    Smith JA, Kauffman CA. Blastomycosis. Proc Am Thorac Soc. 2010;7(3):173–80.CrossRefPubMedGoogle Scholar
  65. 65.
    Randhawa HS, Chowdhary A, Kathuria S, et al. Blastomycosis in India: report of an imported case and current status. Med Mycol. 2013;51(2):185–92.CrossRefPubMedGoogle Scholar
  66. 66.
    Roy M, Benedict K, Deak E, et al. A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering. Clin Infect Dis. 2013;57(5):655–62.CrossRefPubMedGoogle Scholar
  67. 67.
    WHO. Global tuberculosis report 2015. http://www.who.int/tb/publications/global_report/en/. Accessed May 16, 2016.
  68. 68.
    Cantwell MF, McKenna MT, McCray E, Onorato IM. Tuberculosis and race/ethnicity in the United States: impact of socioeconomic status. Am J Respir Crit Care Med. 1998;157(4 Pt 1):1016–20.CrossRefPubMedGoogle Scholar
  69. 69.
    WHO. Tuberculosis and air travel 2013. http://www.who.int/tb/publications/2008/WHO_HTM_TB_2008.399_eng.pdf. Accessed May 16, 2016.
  70. 70.
    Nardell EA, Keegan J, Cheney SA, Etkind SC. Airborne infection. Theoretical limits of protection achievable by building ventilation. Am Rev Respir Dis. 1991;144(2):302–6.CrossRefPubMedGoogle Scholar
  71. 71.
    Centers for Disease Control and Prevention (CDC). Exposure of passengers and flight crew to Mycobacterium tuberculosis on commercial aircraft, 1992-1995. MMWR Morb Mortal Wkly Rep. 1995;44(8):137–40.Google Scholar
  72. 72.
    McFarland JW, Hickman C, Osterholm M, MacDonald KL. Exposure to Mycobacterium tuberculosis during air travel. Lancet. 1993;342(8863):112–3.CrossRefPubMedGoogle Scholar
  73. 73.
    Kenyon TA, Valway SE, Ihle WW, Onorato IM, Castro KG. Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med. 1996;334(15):933–8.CrossRefPubMedGoogle Scholar
  74. 74.
    Cobelens FG, van Deutekom H, Draayer-Jansen IW, et al. Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet. 2000;356(9228):461–5.CrossRefPubMedGoogle Scholar
  75. 75.
    O’Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis. 1987;135(5):1007–14.PubMedGoogle Scholar
  76. 76.
    Tsukamura M, Kita N, Shimoide H, Arakawa H, Kuze A. Studies on the epidemiology of nontuberculous mycobacteriosis in Japan. Am Rev Respir Dis. 1988;137(6):1280–4.CrossRefPubMedGoogle Scholar
  77. 77.
    Maugein J, Dailloux M, Carbonnelle B, Vincent V, Grosset J. Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease. Eur Respir J. 2005;26(6):1092–6.CrossRefPubMedGoogle Scholar
  78. 78.
    Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.CrossRefPubMedGoogle Scholar
  79. 79.
    Harada T, Akiyama Y, Kurashima A, et al. Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases. J Clin Microbiol. 2012;50(11):3556–61.CrossRefPubMedPubMedCentralGoogle Scholar
  80. 80.
    Puthiyakunnon S, Boddu S, Li Y, et al. Strongyloidiasis—an insight into its global prevalence and management. PLoS Negl Trop Dis. 2014;8(8):e3018.CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis. 2001;33(7):1040–7.CrossRefPubMedGoogle Scholar
  82. 82.
    Hynes DM, Weddle T, Smith N, Whittier E, Atkins D, Francis J. Use of health information technology to advance evidence-based care: lessons from the VA QUERI program. J Gen Intern Med. 2010;25(Suppl 1):44–9.CrossRefPubMedPubMedCentralGoogle Scholar
  83. 83.
    Husni RN, Gordon SM, Longworth DL, Adal KA. Disseminated Strongyloides stercoralis infection in an immunocompetent patient. Clin Infect Dis. 1996;23(3):663.CrossRefPubMedGoogle Scholar
  84. 84.
    Rello J, Rodriguez-Morales AJ, Rossolini GM, López-Vélez R, Zahar JR, Leblebicioglu H. Management of infections in critically ill returning travelers in the intensive care unit (I): Considerations on infection control and transmission of resistance. Int J Infect Dis. 2016;. doi: 10.1016/j.ijid.2016.04.019.Google Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Division of Hospital Medicine, Department of Internal MedicineUniversity of California, Davis Medical CenterSacramentoUSA
  2. 2.Division of Infectious Diseases, Department of Internal MedicineUniversity of California, Davis Medical CenterSacramentoUSA

Personalised recommendations